nodes	percent_of_prediction	percent_of_DWPC	metapath
Ondansetron—Local reaction—Pamidronate—Paget's disease of bone	0.0166	0.0171	CcSEcCtD
Ondansetron—Local reaction—Zoledronate—Paget's disease of bone	0.0152	0.0156	CcSEcCtD
Ondansetron—Sleep disturbance—Zoledronate—Paget's disease of bone	0.015	0.0154	CcSEcCtD
Ondansetron—Redness—Pamidronate—Paget's disease of bone	0.0136	0.014	CcSEcCtD
Ondansetron—Redness—Zoledronate—Paget's disease of bone	0.0124	0.0128	CcSEcCtD
Ondansetron—Musculoskeletal pain—Alendronate—Paget's disease of bone	0.0122	0.0126	CcSEcCtD
Ondansetron—Cardiovascular disorder—Risedronate—Paget's disease of bone	0.011	0.0113	CcSEcCtD
Ondansetron—Neoplasm malignant—Pamidronate—Paget's disease of bone	0.0108	0.0111	CcSEcCtD
Ondansetron—Neoplasm malignant—Zoledronate—Paget's disease of bone	0.00984	0.0101	CcSEcCtD
Ondansetron—Musculoskeletal pain—Risedronate—Paget's disease of bone	0.00979	0.0101	CcSEcCtD
Ondansetron—Musculoskeletal pain—Pamidronate—Paget's disease of bone	0.00931	0.00958	CcSEcCtD
Ondansetron—Pain—Tiludronate—Paget's disease of bone	0.00902	0.00927	CcSEcCtD
Ondansetron—Asthma—Etidronic acid—Paget's disease of bone	0.00888	0.00913	CcSEcCtD
Ondansetron—Gastrointestinal pain—Tiludronate—Paget's disease of bone	0.00862	0.00887	CcSEcCtD
Ondansetron—Musculoskeletal pain—Zoledronate—Paget's disease of bone	0.0085	0.00875	CcSEcCtD
Ondansetron—Injection site reaction—Zoledronate—Paget's disease of bone	0.00835	0.00859	CcSEcCtD
Ondansetron—Abdominal pain—Tiludronate—Paget's disease of bone	0.00833	0.00857	CcSEcCtD
Ondansetron—HTR3A—cranial nerve—Paget's disease of bone	0.00803	0.287	CbGeAlD
Ondansetron—Toxic epidermal necrolysis—Alendronate—Paget's disease of bone	0.00788	0.00811	CcSEcCtD
Ondansetron—Stevens-Johnson syndrome—Etidronic acid—Paget's disease of bone	0.00785	0.00807	CcSEcCtD
Ondansetron—Swelling—Pamidronate—Paget's disease of bone	0.00757	0.00779	CcSEcCtD
Ondansetron—Asthma—Alendronate—Paget's disease of bone	0.00757	0.00778	CcSEcCtD
Ondansetron—Asthenia—Tiludronate—Paget's disease of bone	0.00756	0.00778	CcSEcCtD
Ondansetron—Diarrhoea—Tiludronate—Paget's disease of bone	0.00721	0.00742	CcSEcCtD
Ondansetron—Atrial fibrillation—Pamidronate—Paget's disease of bone	0.00705	0.00725	CcSEcCtD
Ondansetron—Sleep disorder—Zoledronate—Paget's disease of bone	0.00705	0.00725	CcSEcCtD
Ondansetron—Dizziness—Tiludronate—Paget's disease of bone	0.00697	0.00717	CcSEcCtD
Ondansetron—Swelling—Zoledronate—Paget's disease of bone	0.00691	0.00711	CcSEcCtD
Ondansetron—Anaphylactoid reaction—Pamidronate—Paget's disease of bone	0.0069	0.0071	CcSEcCtD
Ondansetron—HTR1B—cranial nerve—Paget's disease of bone	0.00674	0.241	CbGeAlD
Ondansetron—Erythema multiforme—Etidronic acid—Paget's disease of bone	0.00672	0.00691	CcSEcCtD
Ondansetron—Stevens-Johnson syndrome—Alendronate—Paget's disease of bone	0.00669	0.00688	CcSEcCtD
Ondansetron—Headache—Tiludronate—Paget's disease of bone	0.0066	0.00679	CcSEcCtD
Ondansetron—Liver function test abnormal—Risedronate—Paget's disease of bone	0.00648	0.00667	CcSEcCtD
Ondansetron—Atrial fibrillation—Zoledronate—Paget's disease of bone	0.00644	0.00662	CcSEcCtD
Ondansetron—Erythema—Etidronic acid—Paget's disease of bone	0.00619	0.00636	CcSEcCtD
Ondansetron—Liver function test abnormal—Pamidronate—Paget's disease of bone	0.00616	0.00634	CcSEcCtD
Ondansetron—Flatulence—Etidronic acid—Paget's disease of bone	0.0061	0.00627	CcSEcCtD
Ondansetron—Haemoglobin—Alendronate—Paget's disease of bone	0.00609	0.00626	CcSEcCtD
Ondansetron—Hypokalaemia—Pamidronate—Paget's disease of bone	0.00608	0.00625	CcSEcCtD
Ondansetron—Asthma—Risedronate—Paget's disease of bone	0.00607	0.00625	CcSEcCtD
Ondansetron—Haemorrhage—Alendronate—Paget's disease of bone	0.00606	0.00623	CcSEcCtD
Ondansetron—Angina pectoris—Risedronate—Paget's disease of bone	0.00591	0.00608	CcSEcCtD
Ondansetron—Erythema multiforme—Alendronate—Paget's disease of bone	0.00573	0.00589	CcSEcCtD
Ondansetron—Bronchospasm—Pamidronate—Paget's disease of bone	0.00568	0.00584	CcSEcCtD
Ondansetron—Angioedema—Etidronic acid—Paget's disease of bone	0.00565	0.00582	CcSEcCtD
Ondansetron—Hypokalaemia—Zoledronate—Paget's disease of bone	0.00555	0.00571	CcSEcCtD
Ondansetron—Erythema—Alendronate—Paget's disease of bone	0.00527	0.00542	CcSEcCtD
Ondansetron—Asthma—Zoledronate—Paget's disease of bone	0.00527	0.00542	CcSEcCtD
Ondansetron—Urinary tract infection—Risedronate—Paget's disease of bone	0.00526	0.00541	CcSEcCtD
Ondansetron—Discomfort—Etidronic acid—Paget's disease of bone	0.0052	0.00535	CcSEcCtD
Ondansetron—Flatulence—Alendronate—Paget's disease of bone	0.00519	0.00534	CcSEcCtD
Ondansetron—Bronchospasm—Zoledronate—Paget's disease of bone	0.00518	0.00533	CcSEcCtD
Ondansetron—Hepatobiliary disease—Risedronate—Paget's disease of bone	0.00512	0.00527	CcSEcCtD
Ondansetron—Urinary tract infection—Pamidronate—Paget's disease of bone	0.005	0.00515	CcSEcCtD
Ondansetron—Ill-defined disorder—Alendronate—Paget's disease of bone	0.00489	0.00503	CcSEcCtD
Ondansetron—Haemoglobin—Risedronate—Paget's disease of bone	0.00488	0.00502	CcSEcCtD
Ondansetron—Haemorrhage—Risedronate—Paget's disease of bone	0.00486	0.005	CcSEcCtD
Ondansetron—Angioedema—Alendronate—Paget's disease of bone	0.00482	0.00496	CcSEcCtD
Ondansetron—Malaise—Alendronate—Paget's disease of bone	0.00475	0.00489	CcSEcCtD
Ondansetron—Haemoglobin—Pamidronate—Paget's disease of bone	0.00464	0.00478	CcSEcCtD
Ondansetron—Haemorrhage—Pamidronate—Paget's disease of bone	0.00462	0.00475	CcSEcCtD
Ondansetron—Urinary tract infection—Zoledronate—Paget's disease of bone	0.00457	0.0047	CcSEcCtD
Ondansetron—Eye disorder—Risedronate—Paget's disease of bone	0.00454	0.00467	CcSEcCtD
Ondansetron—Paraesthesia—Etidronic acid—Paget's disease of bone	0.00453	0.00466	CcSEcCtD
Ondansetron—Cardiac disorder—Risedronate—Paget's disease of bone	0.00451	0.00464	CcSEcCtD
Ondansetron—Chest pain—Alendronate—Paget's disease of bone	0.00449	0.00462	CcSEcCtD
Ondansetron—Discomfort—Alendronate—Paget's disease of bone	0.00443	0.00456	CcSEcCtD
Ondansetron—Angiopathy—Risedronate—Paget's disease of bone	0.00441	0.00454	CcSEcCtD
Ondansetron—Immune system disorder—Risedronate—Paget's disease of bone	0.00439	0.00452	CcSEcCtD
Ondansetron—Mediastinal disorder—Risedronate—Paget's disease of bone	0.00438	0.00451	CcSEcCtD
Ondansetron—Arrhythmia—Risedronate—Paget's disease of bone	0.00434	0.00447	CcSEcCtD
Ondansetron—Constipation—Etidronic acid—Paget's disease of bone	0.00432	0.00444	CcSEcCtD
Ondansetron—Eye disorder—Pamidronate—Paget's disease of bone	0.00432	0.00444	CcSEcCtD
Ondansetron—Bradycardia—Zoledronate—Paget's disease of bone	0.0043	0.00442	CcSEcCtD
Ondansetron—Cardiac disorder—Pamidronate—Paget's disease of bone	0.00429	0.00441	CcSEcCtD
Ondansetron—Flushing—Pamidronate—Paget's disease of bone	0.00429	0.00441	CcSEcCtD
Ondansetron—Angiopathy—Pamidronate—Paget's disease of bone	0.00419	0.00431	CcSEcCtD
Ondansetron—Immune system disorder—Pamidronate—Paget's disease of bone	0.00417	0.00429	CcSEcCtD
Ondansetron—Flatulence—Risedronate—Paget's disease of bone	0.00417	0.00429	CcSEcCtD
Ondansetron—Mediastinal disorder—Pamidronate—Paget's disease of bone	0.00416	0.00428	CcSEcCtD
Ondansetron—Feeling abnormal—Etidronic acid—Paget's disease of bone	0.00416	0.00428	CcSEcCtD
Ondansetron—Chills—Pamidronate—Paget's disease of bone	0.00414	0.00426	CcSEcCtD
Ondansetron—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.00413	0.00425	CcSEcCtD
Ondansetron—Erythema—Pamidronate—Paget's disease of bone	0.00402	0.00414	CcSEcCtD
Ondansetron—Urticaria—Etidronic acid—Paget's disease of bone	0.00401	0.00413	CcSEcCtD
Ondansetron—Abdominal pain—Etidronic acid—Paget's disease of bone	0.00399	0.00411	CcSEcCtD
Ondansetron—Eye disorder—Zoledronate—Paget's disease of bone	0.00394	0.00406	CcSEcCtD
Ondansetron—Cardiac disorder—Zoledronate—Paget's disease of bone	0.00392	0.00403	CcSEcCtD
Ondansetron—Flushing—Zoledronate—Paget's disease of bone	0.00392	0.00403	CcSEcCtD
Ondansetron—Angioedema—Risedronate—Paget's disease of bone	0.00386	0.00398	CcSEcCtD
Ondansetron—Angiopathy—Zoledronate—Paget's disease of bone	0.00383	0.00394	CcSEcCtD
Ondansetron—Immune system disorder—Zoledronate—Paget's disease of bone	0.00381	0.00392	CcSEcCtD
Ondansetron—Mediastinal disorder—Zoledronate—Paget's disease of bone	0.0038	0.00391	CcSEcCtD
Ondansetron—Syncope—Risedronate—Paget's disease of bone	0.00379	0.0039	CcSEcCtD
Ondansetron—Chills—Zoledronate—Paget's disease of bone	0.00379	0.00389	CcSEcCtD
Ondansetron—Arrhythmia—Zoledronate—Paget's disease of bone	0.00377	0.00388	CcSEcCtD
Ondansetron—Ill-defined disorder—Pamidronate—Paget's disease of bone	0.00373	0.00384	CcSEcCtD
Ondansetron—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.00372	0.00383	CcSEcCtD
Ondansetron—Loss of consciousness—Risedronate—Paget's disease of bone	0.00372	0.00382	CcSEcCtD
Ondansetron—Agitation—Pamidronate—Paget's disease of bone	0.0037	0.0038	CcSEcCtD
Ondansetron—Cough—Risedronate—Paget's disease of bone	0.00369	0.0038	CcSEcCtD
Ondansetron—Constipation—Alendronate—Paget's disease of bone	0.00368	0.00378	CcSEcCtD
Ondansetron—Pain—Alendronate—Paget's disease of bone	0.00368	0.00378	CcSEcCtD
Ondansetron—Angioedema—Pamidronate—Paget's disease of bone	0.00367	0.00378	CcSEcCtD
Ondansetron—Erythema—Zoledronate—Paget's disease of bone	0.00367	0.00378	CcSEcCtD
Ondansetron—Malaise—Pamidronate—Paget's disease of bone	0.00363	0.00373	CcSEcCtD
Ondansetron—Syncope—Pamidronate—Paget's disease of bone	0.00361	0.00371	CcSEcCtD
Ondansetron—Chest pain—Risedronate—Paget's disease of bone	0.0036	0.0037	CcSEcCtD
Ondansetron—Anxiety—Risedronate—Paget's disease of bone	0.00359	0.00369	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.00358	0.00368	CcSEcCtD
Ondansetron—Pruritus—Etidronic acid—Paget's disease of bone	0.00357	0.00367	CcSEcCtD
Ondansetron—Feeling abnormal—Alendronate—Paget's disease of bone	0.00355	0.00365	CcSEcCtD
Ondansetron—Loss of consciousness—Pamidronate—Paget's disease of bone	0.00353	0.00364	CcSEcCtD
Ondansetron—Dry mouth—Risedronate—Paget's disease of bone	0.00352	0.00362	CcSEcCtD
Ondansetron—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.00352	0.00362	CcSEcCtD
Ondansetron—Cough—Pamidronate—Paget's disease of bone	0.00351	0.00361	CcSEcCtD
Ondansetron—Convulsion—Pamidronate—Paget's disease of bone	0.00348	0.00358	CcSEcCtD
Ondansetron—Vision blurred—Zoledronate—Paget's disease of bone	0.00346	0.00356	CcSEcCtD
Ondansetron—Diarrhoea—Etidronic acid—Paget's disease of bone	0.00345	0.00355	CcSEcCtD
Ondansetron—Tremor—Zoledronate—Paget's disease of bone	0.00344	0.00354	CcSEcCtD
Ondansetron—Urticaria—Alendronate—Paget's disease of bone	0.00342	0.00352	CcSEcCtD
Ondansetron—Anxiety—Pamidronate—Paget's disease of bone	0.00341	0.00351	CcSEcCtD
Ondansetron—Ill-defined disorder—Zoledronate—Paget's disease of bone	0.00341	0.00351	CcSEcCtD
Ondansetron—Abdominal pain—Alendronate—Paget's disease of bone	0.0034	0.0035	CcSEcCtD
Ondansetron—Body temperature increased—Alendronate—Paget's disease of bone	0.0034	0.0035	CcSEcCtD
Ondansetron—Shock—Risedronate—Paget's disease of bone	0.0034	0.00349	CcSEcCtD
Ondansetron—Nervous system disorder—Risedronate—Paget's disease of bone	0.00339	0.00348	CcSEcCtD
Ondansetron—Discomfort—Pamidronate—Paget's disease of bone	0.00338	0.00348	CcSEcCtD
Ondansetron—Agitation—Zoledronate—Paget's disease of bone	0.00338	0.00347	CcSEcCtD
Ondansetron—Angioedema—Zoledronate—Paget's disease of bone	0.00336	0.00345	CcSEcCtD
Ondansetron—Skin disorder—Risedronate—Paget's disease of bone	0.00335	0.00345	CcSEcCtD
Ondansetron—Malaise—Zoledronate—Paget's disease of bone	0.00331	0.00341	CcSEcCtD
Ondansetron—Syncope—Zoledronate—Paget's disease of bone	0.00329	0.00339	CcSEcCtD
Ondansetron—Anaphylactic shock—Pamidronate—Paget's disease of bone	0.00328	0.00338	CcSEcCtD
Ondansetron—Palpitations—Zoledronate—Paget's disease of bone	0.00325	0.00334	CcSEcCtD
Ondansetron—Shock—Pamidronate—Paget's disease of bone	0.00323	0.00332	CcSEcCtD
Ondansetron—Loss of consciousness—Zoledronate—Paget's disease of bone	0.00323	0.00332	CcSEcCtD
Ondansetron—Nervous system disorder—Pamidronate—Paget's disease of bone	0.00322	0.00331	CcSEcCtD
Ondansetron—Vomiting—Etidronic acid—Paget's disease of bone	0.00321	0.0033	CcSEcCtD
Ondansetron—Cough—Zoledronate—Paget's disease of bone	0.0032	0.0033	CcSEcCtD
Ondansetron—Tachycardia—Pamidronate—Paget's disease of bone	0.0032	0.00329	CcSEcCtD
Ondansetron—Rash—Etidronic acid—Paget's disease of bone	0.00318	0.00328	CcSEcCtD
Ondansetron—Convulsion—Zoledronate—Paget's disease of bone	0.00318	0.00327	CcSEcCtD
Ondansetron—Dermatitis—Etidronic acid—Paget's disease of bone	0.00318	0.00327	CcSEcCtD
Ondansetron—Hypersensitivity—Alendronate—Paget's disease of bone	0.00317	0.00326	CcSEcCtD
Ondansetron—Headache—Etidronic acid—Paget's disease of bone	0.00316	0.00325	CcSEcCtD
Ondansetron—Chest pain—Zoledronate—Paget's disease of bone	0.00313	0.00322	CcSEcCtD
Ondansetron—Anxiety—Zoledronate—Paget's disease of bone	0.00312	0.00321	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.00311	0.00319	CcSEcCtD
Ondansetron—Paraesthesia—Risedronate—Paget's disease of bone	0.0031	0.00319	CcSEcCtD
Ondansetron—Discomfort—Zoledronate—Paget's disease of bone	0.00309	0.00318	CcSEcCtD
Ondansetron—Asthenia—Alendronate—Paget's disease of bone	0.00309	0.00318	CcSEcCtD
Ondansetron—CYP1A2—urine—Paget's disease of bone	0.00308	0.11	CbGeAlD
Ondansetron—Dyspnoea—Risedronate—Paget's disease of bone	0.00308	0.00317	CcSEcCtD
Ondansetron—Hypotension—Pamidronate—Paget's disease of bone	0.00307	0.00315	CcSEcCtD
Ondansetron—Dry mouth—Zoledronate—Paget's disease of bone	0.00306	0.00315	CcSEcCtD
Ondansetron—Pruritus—Alendronate—Paget's disease of bone	0.00304	0.00313	CcSEcCtD
Ondansetron—Anaphylactic shock—Zoledronate—Paget's disease of bone	0.003	0.00308	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.00298	0.00307	CcSEcCtD
Ondansetron—Fatigue—Risedronate—Paget's disease of bone	0.00298	0.00306	CcSEcCtD
Ondansetron—Pain—Risedronate—Paget's disease of bone	0.00295	0.00304	CcSEcCtD
Ondansetron—Constipation—Risedronate—Paget's disease of bone	0.00295	0.00304	CcSEcCtD
Ondansetron—Shock—Zoledronate—Paget's disease of bone	0.00295	0.00303	CcSEcCtD
Ondansetron—Paraesthesia—Pamidronate—Paget's disease of bone	0.00295	0.00303	CcSEcCtD
Ondansetron—Diarrhoea—Alendronate—Paget's disease of bone	0.00294	0.00303	CcSEcCtD
Ondansetron—Nervous system disorder—Zoledronate—Paget's disease of bone	0.00294	0.00302	CcSEcCtD
Ondansetron—Dyspnoea—Pamidronate—Paget's disease of bone	0.00293	0.00301	CcSEcCtD
Ondansetron—Tachycardia—Zoledronate—Paget's disease of bone	0.00293	0.00301	CcSEcCtD
Ondansetron—CYP2C9—urine—Paget's disease of bone	0.00292	0.104	CbGeAlD
Ondansetron—Somnolence—Pamidronate—Paget's disease of bone	0.00292	0.003	CcSEcCtD
Ondansetron—Skin disorder—Zoledronate—Paget's disease of bone	0.00291	0.003	CcSEcCtD
Ondansetron—Dizziness—Alendronate—Paget's disease of bone	0.00285	0.00293	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.00283	0.00291	CcSEcCtD
Ondansetron—Fatigue—Pamidronate—Paget's disease of bone	0.00283	0.00291	CcSEcCtD
Ondansetron—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.00282	0.0029	CcSEcCtD
Ondansetron—Pain—Pamidronate—Paget's disease of bone	0.00281	0.00289	CcSEcCtD
Ondansetron—Constipation—Pamidronate—Paget's disease of bone	0.00281	0.00289	CcSEcCtD
Ondansetron—Hypotension—Zoledronate—Paget's disease of bone	0.0028	0.00288	CcSEcCtD
Ondansetron—CYP2E1—urine—Paget's disease of bone	0.00277	0.099	CbGeAlD
Ondansetron—Urticaria—Risedronate—Paget's disease of bone	0.00274	0.00282	CcSEcCtD
Ondansetron—Vomiting—Alendronate—Paget's disease of bone	0.00274	0.00281	CcSEcCtD
Ondansetron—Abdominal pain—Risedronate—Paget's disease of bone	0.00273	0.00281	CcSEcCtD
Ondansetron—Body temperature increased—Risedronate—Paget's disease of bone	0.00273	0.00281	CcSEcCtD
Ondansetron—Rash—Alendronate—Paget's disease of bone	0.00271	0.00279	CcSEcCtD
Ondansetron—Dermatitis—Alendronate—Paget's disease of bone	0.00271	0.00279	CcSEcCtD
Ondansetron—Feeling abnormal—Pamidronate—Paget's disease of bone	0.0027	0.00278	CcSEcCtD
Ondansetron—Headache—Alendronate—Paget's disease of bone	0.0027	0.00277	CcSEcCtD
Ondansetron—Paraesthesia—Zoledronate—Paget's disease of bone	0.00269	0.00277	CcSEcCtD
Ondansetron—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.00268	0.00276	CcSEcCtD
Ondansetron—Dyspnoea—Zoledronate—Paget's disease of bone	0.00267	0.00275	CcSEcCtD
Ondansetron—Somnolence—Zoledronate—Paget's disease of bone	0.00266	0.00274	CcSEcCtD
Ondansetron—Body temperature increased—Pamidronate—Paget's disease of bone	0.00259	0.00267	CcSEcCtD
Ondansetron—Abdominal pain—Pamidronate—Paget's disease of bone	0.00259	0.00267	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.00259	0.00266	CcSEcCtD
Ondansetron—Fatigue—Zoledronate—Paget's disease of bone	0.00258	0.00266	CcSEcCtD
Ondansetron—Pain—Zoledronate—Paget's disease of bone	0.00256	0.00264	CcSEcCtD
Ondansetron—Constipation—Zoledronate—Paget's disease of bone	0.00256	0.00264	CcSEcCtD
Ondansetron—Hypersensitivity—Risedronate—Paget's disease of bone	0.00254	0.00262	CcSEcCtD
Ondansetron—Asthenia—Risedronate—Paget's disease of bone	0.00248	0.00255	CcSEcCtD
Ondansetron—Feeling abnormal—Zoledronate—Paget's disease of bone	0.00247	0.00254	CcSEcCtD
Ondansetron—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.00245	0.00252	CcSEcCtD
Ondansetron—Pruritus—Risedronate—Paget's disease of bone	0.00244	0.00251	CcSEcCtD
Ondansetron—Hypersensitivity—Pamidronate—Paget's disease of bone	0.00242	0.00249	CcSEcCtD
Ondansetron—Urticaria—Zoledronate—Paget's disease of bone	0.00238	0.00245	CcSEcCtD
Ondansetron—Abdominal pain—Zoledronate—Paget's disease of bone	0.00237	0.00244	CcSEcCtD
Ondansetron—Body temperature increased—Zoledronate—Paget's disease of bone	0.00237	0.00244	CcSEcCtD
Ondansetron—Diarrhoea—Risedronate—Paget's disease of bone	0.00236	0.00243	CcSEcCtD
Ondansetron—Asthenia—Pamidronate—Paget's disease of bone	0.00235	0.00242	CcSEcCtD
Ondansetron—Pruritus—Pamidronate—Paget's disease of bone	0.00232	0.00239	CcSEcCtD
Ondansetron—Dizziness—Risedronate—Paget's disease of bone	0.00228	0.00235	CcSEcCtD
Ondansetron—Diarrhoea—Pamidronate—Paget's disease of bone	0.00225	0.00231	CcSEcCtD
Ondansetron—CYP3A4—urine—Paget's disease of bone	0.00223	0.0797	CbGeAlD
Ondansetron—Hypersensitivity—Zoledronate—Paget's disease of bone	0.00221	0.00227	CcSEcCtD
Ondansetron—Vomiting—Risedronate—Paget's disease of bone	0.00219	0.00226	CcSEcCtD
Ondansetron—CYP2D6—urine—Paget's disease of bone	0.00219	0.0784	CbGeAlD
Ondansetron—Rash—Risedronate—Paget's disease of bone	0.00218	0.00224	CcSEcCtD
Ondansetron—Dermatitis—Risedronate—Paget's disease of bone	0.00217	0.00224	CcSEcCtD
Ondansetron—Dizziness—Pamidronate—Paget's disease of bone	0.00217	0.00223	CcSEcCtD
Ondansetron—Headache—Risedronate—Paget's disease of bone	0.00216	0.00222	CcSEcCtD
Ondansetron—Asthenia—Zoledronate—Paget's disease of bone	0.00215	0.00221	CcSEcCtD
Ondansetron—Pruritus—Zoledronate—Paget's disease of bone	0.00212	0.00218	CcSEcCtD
Ondansetron—Vomiting—Pamidronate—Paget's disease of bone	0.00209	0.00215	CcSEcCtD
Ondansetron—Rash—Pamidronate—Paget's disease of bone	0.00207	0.00213	CcSEcCtD
Ondansetron—Dermatitis—Pamidronate—Paget's disease of bone	0.00207	0.00213	CcSEcCtD
Ondansetron—Headache—Pamidronate—Paget's disease of bone	0.00206	0.00211	CcSEcCtD
Ondansetron—Diarrhoea—Zoledronate—Paget's disease of bone	0.00205	0.00211	CcSEcCtD
Ondansetron—Dizziness—Zoledronate—Paget's disease of bone	0.00198	0.00204	CcSEcCtD
Ondansetron—Vomiting—Zoledronate—Paget's disease of bone	0.00191	0.00196	CcSEcCtD
Ondansetron—Rash—Zoledronate—Paget's disease of bone	0.00189	0.00194	CcSEcCtD
Ondansetron—Dermatitis—Zoledronate—Paget's disease of bone	0.00189	0.00194	CcSEcCtD
Ondansetron—Headache—Zoledronate—Paget's disease of bone	0.00188	0.00193	CcSEcCtD
